News About: Pharm. Industry
EDI reported Plavix as the top prescription drug in 2006.
Plavix, a foreign brand prescription drug of Sanofi-Aventis, showed the top on the EDI bill changes last year while Amodipine of Hanmi kept the top among the local brands according to the 2006 EDI bill report.
...
Concerns are rising over less benefits in minor disease
The government's plan to lower health insurance benefits for treatment of minor diseases, such as common cold, from August has sparked a concern that the plan will significantly reduce the number of prescriptions, des...
Lilly to launch anti-osteoporosis drug, Fosteo.
Lilly Korea announced to launch Fosteo (teriparatide), a unique anti-osteoporosisdrug, for the promotion of bone formation.
Fosteo is a parathyroidal hormone to promote a bone formation instead of blocking an excre...
Use of RFID tags to be mandatory in drugs
The government plans to employ the radio frequency identification (RFID) or smart sensor technologies in drugs and foods, starting to replace the current barcodes as early as next year.
The RFID tag is a small inte...
Foreign-invested pharmaceutical firms increase market share
With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.
According to Mirae Asset ...
Once-a-month drug for osteoporosis soon to launch.
A tensional atmosphere seems to surface to the 130 billion won worth of anti-osteoporosis drug markets by upcoming market launch of a new once-a-month administering drug, perhaps within this week at the earlist.
C...
Phase II study for Zydena successfully completed in U. S.
The phase II clinical study of Zydena in the United States was successfully completed and may give a good chance for its FDA approval in due course.
Dong-A PharmTec, a subsidiary of Dong-A playing a major role for ...
Hanmi wins gemicitabine patent
Hanmi Pharm announced on April it acquired a Korean patent related to a core technology of producing gemcitabine intermediate, entitled 1--halo-2,2-difluoro-2-deoxy-D-ribofuranose derivative and its manufacturing meth...
Sanofi's Actonel added indication for male osteoporosis.
Sanofi-Aventis Korea announced that the KFDA recently approved an additional indication of Actonel (risedronate sodium) for the treatment of male osteoporosis.
Actonel is a derivative of the bisphonphonates for the...
Ex-medical doctor named MSD's science ambassador
MSD Korea said on April 17 that the U.S.-based Merck Institute named Kim Kyu-chan, former Ex-medical doctor of Eulgi Hospital as a science of ambassador in Asia-Pacific region.
Kim, 57, will play a vital role in sc...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
March
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
23 | 24 | 25 | 26 | 27 | 28 | 1 |
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 | 31 | 1 | 2 | 3 | 4 | 5 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
